Institutional investors purchased a net $635.8 thousand shares of CLSN during the quarter ended September 2017 and now own 4.60% of the total shares outstanding. This is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 259.8 Thousand shares of Celsion Corp
T. ROWE PRICE ASSOCIATES, INC. Bought 60.2 Thousand shares of Celsion Corp